Article
A Polygenic and Phenotypic Risk Prediction for Polycystic Ovary Syndrome Evaluated by Phenome-Wide Association Studies.
The Journal of clinical endocrinology and metabolism - 1 Jun 2020
Joo Yoonjung Yoonie, Actkins Ky'Era, Pacheco Jennifer A, Basile Anna O, Carroll Robert, Crosslin David R, Day Felix, Denny Joshua C, Velez Edwards Digna R, Hakonarson Hakon, Harley John B, Hebbring Scott J, Ho Kevin, Jarvik Gail P, Jones Michelle, Karaderi Tugce, Mentch Frank D, Meun Cindy, Namjou Bahram, Pendergrass Sarah, Ritchie Marylyn D, Stanaway Ian B, Urbanek Margrit, Walunas Theresa L, Smith Maureen, Chisholm Rex L, Kho Abel N, Davis Lea, Hayes M Geoffrey
Abstract excerpt
CONTEXT: As many as 75% of patients with polycystic ovary syndrome (PCOS) are estimated to be unidentified in clinical practice. OBJECTIVE: Utilizing polygenic risk prediction, we aim to identify the phenome-wide comorbidity patterns characteristic of PCOS to improve accurate diagnosis and preventive treatment. DESIGN, PATIENTS, AND METHODS: Leveraging the electronic health records (EHRs) of 124 852 individuals,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
